Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=gnbtLatest Financial News for Generex Biotechnology Corporatien-usTue, 15 Dec 2009 15:03:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091215/2640_id.html?.v=1Shares of Array BioPharma surged on Tuesday after the small-cap company signed a $60 million deal.yahoo_finance/2037873791Tue, 15 Dec 2009 15:03:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180332.html?.v=1WORCESTER, Mass. -- On December 14, 2009, Generex Biotechnology Corporation issued a press release announcing the presentation of interim results from a Phase II efficacy study of a novel immunotherapeutic vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. , at the 32nd Annual San Antonio Breast Cancer Symposium .yahoo_finance/1340738057Tue, 15 Dec 2009 14:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091214/us_generex_cancer_vaccine.html?.v=1Biotech drugmaker Generex on Monday reported positive results for a mid-stage study of its experimental cancer vaccine. The company said data after 13 months showed only half of breast cancer patients who received the company's vaccine relapsed, compared with those not taking the vaccine.yahoo_finance/3553274948Mon, 14 Dec 2009 23:01:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12lej0rso/*http%3A//www.marketwatch.com/news/story/sunesis-generex-cubist-lead-drug/story.aspx?guid=%7B418E0650%2D51E6%2D41E5%2D9E3C%2DD543A243289B%7D&siteid=yhoofSunesis Pharmaceuticals help pace drug stocks' gains, as the drug developer continues its upward trek after soaring last week on positive news about its new leukemia drug.yahoo_finance/2443544601Mon, 14 Dec 2009 18:29:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180167.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation today announced presentation of interim results from a Phase II efficacy study of a novel immunotherapeutic vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. .yahoo_finance/2740825866Mon, 14 Dec 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/gnbt10-q.htmlyahoo_finance/2892185540Fri, 11 Dec 2009 21:34:24 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12jpg3r4f/*http%3A//www.marketwatch.com/news/story/drug-stocks-trend-lower-pfizer/story.aspx?guid=%7BDB9F5504%2D8272%2D4CDF%2DBAF5%2DDA28BE2DC0B0%7D&siteid=yhoofDrug stocks join the broader market in negative territory.yahoo_finance/2146790507Wed, 9 Dec 2009 19:34:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091209/us_generex_sanofi_aventis.html?.v=2Generex Biotechnology Corp. said Wednesday it entered a supply agreement with Sanofi-Aventis that will give Generex the insulin it needs to test and market its diabetes drug candidate Generex Oral-lyn.yahoo_finance/2279712150Wed, 9 Dec 2009 17:15:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/gnbt8-k.htmlyahoo_finance/550185542Wed, 9 Dec 2009 14:35:58 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091209/179907.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has signed a long-term agreement with Sanofi-Aventis Deutschland GmbH for the manufacture and supply of recombinant human insulin crystals for commercial and clinical trial use in Generex's proprietary buccal insulin spray product, Generex Oral-lyn.yahoo_finance/771175338Wed, 9 Dec 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=133uc78oi/*http%3A//www.fool.com/investing/general/2009/12/07/4-more-stocks-on-wall-streets-dollar-menu.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/4169809609Mon, 7 Dec 2009 21:17:49 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091207/179757.html?.v=1DALLAS -- BeaconEquity.com announces an investment report featuring Generex Biotechnology Corp.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.yahoo_finance/3289683017Mon, 7 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12gm26i3q/*http%3A//www.marketwatch.com/news/story/endo-falls-fda-move-generex/story.aspx?guid=%7BF693B301%2D1ABA%2D4558%2DAF97%2D697EE0E2C228%7D&siteid=yhoofDrug stocks gain ground in morning activity while shares of Endo Pharmaceuticals fall on news that U.S. regulators have declined to approve its hormone therapy Aveed for the treatment of low testosterone in men.yahoo_finance/3697982977Thu, 3 Dec 2009 17:25:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12g6pvjte/*http%3A//www.marketwatch.com/news/story/drug-stocks-gain-endo-falls/story.aspx?guid=%7BF693B301%2D1ABA%2D4558%2DAF97%2D697EE0E2C228%7D&siteid=yhoofyahoo_finance/3784716914Thu, 3 Dec 2009 15:34:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091203/179533.html?.v=1WORCESTER, Mass. -- Published in the journal Diabetes, Obesity and Metabolism, an independent review of clinical trials of Generex Oral-lyn shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously.yahoo_finance/2179039317Thu, 3 Dec 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091201/179317.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that the Company's proprietary Crave-NX 7-Day Diet Aid Spray will soon be available in Duane Reade's 256 drugstores throughout New York City.yahoo_finance/1965144851Tue, 1 Dec 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091123/178970.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. , Generex's wholly-owned immunotherapeutics subsidiary, made a presentation on the Company's H1N1 Swine Flu program at a national symposium on influenza.yahoo_finance/1022950578Mon, 23 Nov 2009 15:47:23 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091110/gnbt8-k.htmlyahoo_finance/1647517409Tue, 10 Nov 2009 21:02:18 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091110/us_generex_biotechnology_nasdaq_listing.html?.v=1Generex Biotechnology Corp. said Tuesday it has an additional 180 calendar days to regain compliance with the NASDAQ Stock Market's listing maintenance requirements.yahoo_finance/2102901197Tue, 10 Nov 2009 20:48:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178093.html?.v=1WORCESTER, Mass. -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received confirmation from The NASDAQ Stock Market that the Company will be provided with an additional 180 calendar day period to regain compliance with the Capital Market's listing maintenance requirements.yahoo_finance/1172147116Tue, 10 Nov 2009 20:00:00 Etc/GMT